Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Vyome officially went public today NASDAQ: RSLS. Premarket RS and now a tiny float. Major price swing today between $5 - $12. settled at $8. I think this will go really high soon. As for LICH, we are a Vyome asset in waiting for now. I take solace in the fact that we are part of a great company. Our day will come! Keep the faith!
Vyome has many Indian Biotech startups as part of their social network. I'm LinkedIn with Venkat and Shila and I see the enormous social network they have. I'm sure LICH will either be used by Vyome for a subsidiary or sold to another Indian biotech company - Indians tend to stick together and help each other out. We'll be surprised one day. Until then, the waiting game continues...
Thanks Dubbie! Nothing new in the Q as expected, but glad to see Venkat is filing on time and keeping LICH current!
Interesting. Would be funny if Vyome pulls out of the RSLS merger because of ongoing litigation and ends up rethinking OTC and LICH. In any case I think LICH will emerge in a good place one day since it is a clean shell with no baggage. I'm always the optimist :)
We wait for the Vyome board to decide if they want to use the shell for a subsidiary company or sell it to another Biotech startup friend of theirs. Either way it will have value one day. So I'm holding for better days ahead, whenever that may be.
The good news is the shell is owned by a Vyome - a reputable biotech company, which will soon be a Nasdaq company. So, whatever they use it for... a subsidiary, or if they sell it, it will be a will be a professional situation. So we can take solace in knowing that at some point something good will come of LICH.
Good luck! I think he thought I was you yesterday. He said - I remember speaking with you - you are the writer, right? :)
Yes. The more I think about it they will most likely LICH at some point for other companies under their umbrella. I got the sense that Venkat had a plan for it, but he wasn't sharing any details.
No real choice but to wait it out. As we saw yesterday with Vyome, things mysteriously happen when you least expect them to.
Update from Venkat: I just got off the phone with Venkat. To my surprise he picked up the phone, and we had a nice conversation. The bottom line is he has nothing to say about LICH. He said that right now he is focussing on their current merger. He was very gracious and upbeat, but would only say that when they have plans for LICH he will issue a press Release. He stuck to that mantra throughout our conversation. That's the gist of it.
Yes, maybe. As a holding company now, they my spin off a subsidiary.
Im wondering since they will now be called Vyome Holdings, if the use LICH for a subsidiary company?
Hi All, I can't sugar coat this. Vyome went public today through a merger with a Nasdaq company "HIND". I have reached out to Shila and Venkat to try and find out the future of the LICH ticker and waiting to hear back. I assume they sell it at this point but who knows. LICH is a good clean shell with a perfect share structure and I'm sure something will eventually come of it. I'll update the board if I hear anything.
https://www.globenewswire.com/news-release/2024/07/09/2910618/0/en/Vyome-to-go-public-and-trade-on-the-Nasdaq-Capital-Market-under-the-ticker-symbol-HIND.html
Shiladitya Sengupta (Shila) just liked a LinkedIn post regarding crossover rounds. Shila is the founder of Vyome. https://www.linkedin.com/in/shiladitya-sengupta-8441bb1/recent-activity/reactions/
It may mean nothing, but I just find it interesting that he liked this post. Shows what's on his mind. A crossover round is a type of venture financing where investors participate significantly in a private company's capital raise, and are often used by companies planning an initial public offering (IPO), especially in the life sciences industry. So we have 4 major Series D Vyome investors, Iron Pillar being the largest, all looking for a big pay day. I think we are experiencing the quiet before the storm. IMHO
Anyone with a couple of hundred bucks can wildly swing this stock up or down. When buying starts "one day" the upside will be exponential. Hard watching this right now.
Sure. just did, My email address ends with a 3.
Back to Pink! Now we just need some real news!
Who knows at this point. They could also use the Shell for one pathway (subsidiary) of Vyome Therapeutics, Inc. I.e.. Vyome Therapeutics Limited. This will allow them to raise capital for a specific drug for clinical trials without going full public with Vyome therapeutics, Inc. Just a theory.
Quarterly Filed. I read through it and no changes noted.
https://www.otcmarkets.com/otcapi/company/financial-report/404781/content
Yeah, it seems a bit goofy that he would not a file the quarterly on time, especially if it is just a copy of the last one with a new date. Perhaps it's late because of additional filings his law firm are working on in conjunction with the quarterly? That is my hope. But he just may be late because he is late.
Just tried calling Venkat. Went to voicemail as expected. The ringtone was US, not overseas, and voicemail actually worked - it was not filled up. Fingers crossed he is in Princeton working on the merger now.
The Board members have huge investments in Vyome. These guys are looking for a huge pay day. We're along for the ride!
https://www.vyometx.com/people.html
I have no idea about restricted shares. All I know is it was nice to close green on a Friday!
I don't think we need to worry too much about that here. We are so used to dealing with scum OTC scam companies that we become jaded, myself included. We have to remember that this is a very reputable Biotech Company. Their founder (Shila) is a Harvard professor and innovator, and very well respected person. I know him. While I don't have a crystal ball and nothing is for certain, I am invested here because I feel good about the company and the honorable people who run it. That is just one mans opinion.
What we have going for us is the tiny float, and a company that when they receive FDA approvals will be so valuable that there will be tremendous buying pressure, which will bust through roadblocks. At least that is my hope. In any case we should shoot up hard at the first signs of merger news.
Huge PPS swings today with not much more than beer money.
Easy!
To put things in perspective for those who may be new to LICH. Float is 108M and locked. Vyome who owns the LICH shell is a very legit and groundbreaking Biotech company with significant IP that can take a huge chunk of the immuno-inflammatory therapeutics market share (multi-billions).
https://www.otcmarkets.com/stock/LICH/security
https://www.vyometx.com
:) If a few bucks can move the needle like this, imagine when there is major buying on announcement day! I'm not kidding when I say this could easily get into the dollars!
Amazing how with just light volume the PPS nearly doubles. Float is so tight! When Vyome officially goes public we will shoot into dollars IMHO. That day will come. Hopefully soon!
Something must be brewing. Venkat has been silent on social media for a few weeks now, and seems there is some LICH volume. With OTC exploding all over, this would be the perfect time to go public. Feels like we are very close. Fingers crossed this will explode soon!
Reverse Split? They need a Reverse Merger first to bring Vyome into LICH. I don't think we need to be concerned with any splits at this point. As of now LICH is just a clean shell waiting with open arms for Vyome.
Sure thing! Obviously, going public is weighing heavy on his mind. Just a matter of when.
Per the Joseph Lucoski post... https://www.linkedin.com/feed/update/urn:li:activity:7181305333057753089/
"Will the microcap markets follow? Stay tuned for our 1st Quarter Microcap IPO update coming out later this week!"
Lets keep an eye on that! Venkat will be following I'm sure.
Venkat just 'Liked" this post. A good sign!
Joseph Lucoski LinkedIn:
https://www.linkedin.com/feed/update/urn:li:activity:7181293813443776512/
Source Article:
https://markets.businessinsider.com/news/stocks/recent-upcoming-ipo-processes-stock-market-impact-outlook-reddit-astera-2024-4
For sure. Something is cooking.
Venkat liked this post today on LinkedIn. He is planning and plotting I'm sure.
https://www.linkedin.com/feed/update/urn:li:activity:7174113255630503937/
Probably due to their current Pink Limited and Unsolicited quotes only status. Im surprised the Yield sign didn't come off yet since they filed their Q on 02/26. Perhaps on Monday it will return to Pink current.
Only difference is the new OTC Markets Template. Other than that no change. I feel very optimistic about that fact that they just got all their filing ducks in order. They can't stay a shell much longer. The fact that they just filed attorney letter and quarterly leads me to believe they are close. If they were going to let it lapse they would't have spent all the money or effort to stay current. They are keeping current for a reason. On a side note... Venkat has gone dark the past 2 weeks on his social media postings. Perhaps he's busy on planning the RM? I can dream cant I :) I do have a feeling we will hear something very soon.
LOL!
Confucius say "The quiet toad catches the fly"